FDA approves Samsung Bioepis’ EPYSQLI as Soliris biosimilar
Samsung Bioepis has announced the approval of EPYSQLI BLA by the US Food and Drug Administration (FDA) as a biosimilar to Soliris.
Samsung Bioepis has announced the approval of EPYSQLI BLA by the US Food and Drug Administration (FDA) as a biosimilar to Soliris.
What's Your Reaction?
